Biology of Non-clear Cell Renal Cancer Subtypes: KCRS23 Session One | KidneyCAN скачать в хорошем качестве

Biology of Non-clear Cell Renal Cancer Subtypes: KCRS23 Session One | KidneyCAN

Note: Time stamps for specific speaker presentations, along with speaker slides, are available at https://kcrs.kidneycan.org/kcrs23-pre... Join us for the second session of KCRS23, where we delve into the biology of non-clear cell renal cancer subtypes. This session is moderated by Srinivas Viswanathan from Dana-Farber Cancer Institute and Elizabeth Henske from Brigham and Women’s Hospital. Our esteemed panel of speakers includes Jung Wook Park from Duke Cancer Institute, Kaushal Asrani from Johns Hopkins University, Srinivas Viswanathan from Dana-Farber Cancer Institute, and Elizabeth Henske from Brigham and Women's Hospital. They discuss a range of topics, including defining cellular and genetic factors for renal cell carcinoma subtypes, targeting GPNMB in renal tumors in tuberous sclerosis complex and translocation renal cell carcinoma, deep functional characterization of MiT/TFE fusions in translocation renal cell carcinoma, and targeting TFEB and TFE3 in renal tumorigenesis. KidneyCAN hosted the fifth annual Kidney Cancer Research Summit on July 13-14, 2023. #KCRS23 is a meeting of clinicians, researchers, research advocates, scientists, medical oncologists, industry and others to discuss the future efforts for collaboration in the field of kidney cancer research. Learn more about KCRS at https://kcrs.kidneycan.org KidneyCAN is a registered 501(c)(3) nonprofit grassroots organization dedicated to funding and finding a cure for kidney cancer. The mission of KidneyCAN is to abolish kidney cancer as a threat to the life and health of patients by supporting patient advocacy and research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Learn more about KidneyCAN at https://kidneycan.org Together, we are accelerating cures for #kidneycancer.